|Cris Calsada||Chief Financial Officer|
|Jay Hagan||President and Chief Executive Officer|
|Denis Drygin||Chief Scientific Officer|
|Yanan Zhu||Wells Fargo Securities.|
|Andreas Argyrides||Wedbush Securities|
|Yi Chen||H.C. Wainwright|
Ladies and gentlemen, thank you for standing by and welcome to the Regulus Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants lines are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to Cris Calsada, Chief Financial Officer of Regulus Therapeutics.